1160.67.47001 Boehringer Ingelheim Investigational Site

Oslo

0 studies enrolling now · 1 studies all time

What they study most

Coronary Disease

Studies at this site

• RE-DEEM Dose Finding Study for Dabigatran Etexilate in Patients With Acute Coronary Syndrome — Completed